Engineered proteins pull double duty.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 20371477.
- Also identified by DOI 10.1126/scitranslmed.3000276.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Myriad bi-specific proteins have been developed that recognize two different clinical targets, with the goal of achieving enhanced therapeutic effects as compared with proteins that interact with only one target. These engineered proteins are starting to enter clinical testing for a variety of biomedical applications, particularly cancer treatment.
Medical subject headings
- Protein Engineering
- Proteins